True Drinks (OTCMKTS: TRUU) and MediWound (NASDAQ:MDWD) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

Valuation & Earnings

This table compares True Drinks and MediWound’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
True Drinks $2.58 million 0.84 -$5.44 million N/A N/A
MediWound $2.50 million 71.41 -$22.14 million ($0.62) -10.65

True Drinks has higher revenue and earnings than MediWound.

Insider & Institutional Ownership

32.5% of MediWound shares are owned by institutional investors. 10.1% of True Drinks shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and recommmendations for True Drinks and MediWound, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
True Drinks 0 0 0 0 N/A
MediWound 0 0 6 0 3.00

MediWound has a consensus price target of $10.17, indicating a potential upside of 54.04%. Given MediWound’s higher possible upside, analysts clearly believe MediWound is more favorable than True Drinks.


This table compares True Drinks and MediWound’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
True Drinks -165.55% -476.68% -141.06%
MediWound -904.12% -226.62% -36.64%

Risk & Volatility

True Drinks has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, MediWound has a beta of -0.19, meaning that its stock price is 119% less volatile than the S&P 500.


MediWound beats True Drinks on 6 of the 11 factors compared between the two stocks.

True Drinks Company Profile

True Drinks Holdings, Inc. develops, markets, sells, and distributes naturally flavored water in the United States. The company offers AquaBall Naturally Flavored Water, a vitamin-enhanced and naturally flavored water drink. It also markets and distributes Bazi All Natural Energy, a liquid nutritional supplement drink. True Drinks Holdings, Inc. distributes its products through various retail channels, such as grocery stores, mass merchandisers, drug stores, and convenience stores, as well as through online retailers. The company was formerly known as True Drinks, Inc. and changed its name to True Drinks Holdings, Inc. in October 2012. True Drinks Holdings, Inc. was founded in 2008 and is headquartered in Irvine, California.

MediWound Company Profile

MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns in the European Union, Israel, and Argentina. The company also develops EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Receive News & Ratings for True Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for True Drinks and related companies with's FREE daily email newsletter.